acetazolamide NDC 65841-762

NDC codes

FDA NDC Directory

Product NDC (as listed)65841-762Labeler and product segments. Claims need a package NDC.

Product NDC at billing width65841-0762Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
65841-762-01	65841076201	100 CAPSULE in 1 BOTTLE (65841-762-01)Marketed from Apr 10, 2019
65841-762-05	65841076205	500 CAPSULE in 1 BOTTLE (65841-762-05)Marketed from Apr 10, 2019
65841-762-06	65841076206	30 CAPSULE in 1 BOTTLE (65841-762-06)Marketed from Apr 10, 2019
65841-762-10	65841076210	1000 CAPSULE in 1 BOTTLE (65841-762-10)Marketed from Apr 10, 2019
65841-762-16	65841076216	90 CAPSULE in 1 BOTTLE (65841-762-16)Marketed from Apr 10, 2019
65841-762-30	65841076230	10 BLISTER PACK in 1 CARTON (65841-762-30) / 10 CAPSULE in 1 BLISTER PACKMarketed from Apr 10, 2019

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): acetazolamide
Generic name (nonproprietary): acetazolamide
Active ingredients: Acetazolamide — 500 mg/1
Dosage form: Capsule
Route: Oral
Labeler: Zydus Lifesciences Limited
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 205301
Marketing start: Apr 10, 2019
Listing expires: Dec 31, 2026
Other FDA classes: Carbonic Anhydrase Inhibitors (Mechanism)Sulfonamides (Chemical structure)
Identifiers: Product ID 65841-762_bb74273d-215a-4983-bfa1-7d649f6872d5SPL ID bb74273d-215a-4983-bfa1-7d649f6872d5SPL set ID 2c1d9078-c15f-4dce-bc26-edfa5400fa9bRxCUI 562524UNII O3FX965V0IUPC 0365841762013
Pharmacologic class: Carbonic Anhydrase Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N465841076201 followed by a unit qualifier and the quantity

Package 65841-0762-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Oct 8, 2024.

Indications (excerpt from the label)

INDICATIONS AND USAGE: For adjunctive treatment of: chronic simple (open-angle) glaucoma, secondary glaucoma, and preoperatively in acute angle-closure glaucoma where delay of surgery is desired in order to lower intraocular pressure. Acetazolamide extended-release capsules are also indicated for the prevention or amelioration of symptoms associated with acute mountain sickness despite gradual ascent.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 205301

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 205301
Product	Strength	Form · route	Labeler	Product NDC
acetazolamide	Acetazolamide 500 mg/1	CapsuleOral	American Health Packaging	60687-578
acetazolamide	Acetazolamide 500 mg/1	CapsuleOral	Zydus Pharmaceuticals (USA) Inc.	70710-1591